Non-invasive Prenatal Testing Market by Product, Method, Test Type, Application, End User - Global Forecast 2025-2030- Product Image

Sale

Non-invasive Prenatal Testing Market by Product, Method, Test Type, Application, End User - Global Forecast 2025-2030

Report
186 Pages
October 2024
Region: Global
360iResearch™
ID: 4968595

UP TO €668EUR$697USD£557GBP OFF until Dec 31^st 2024

The Non-invasive Prenatal Testing Market grew from USD 7.40 billion in 2023 to USD 7.80 billion in 2024. It is expected to continue growing at a CAGR of 5.47%, reaching USD 10.75 billion by 2030.

Non-invasive prenatal testing (NIPT) is revolutionizing maternal-fetal medicine by offering a safer, effective method to screen for genetic abnormalities such as Down syndrome, trisomy 18, and trisomy 13. The scope of NIPT is vast, spanning across its necessity in achieving early detection and intervention without the risk associated with invasive procedures like amniocentesis. The application of NIPT extends to expectant mothers seeking peace of mind regarding their newborn's health, healthcare providers aiming for precision in prenatal diagnosis, and laboratories dedicated to advancing genetic testing technologies. With the rising trend of delayed pregnancies and increased prenatal screening awareness, the NIPT market is witnessing substantial growth. Key factors driving this include advancements in genomics, increasing acceptance of DNA-based tests, and healthcare policies supporting preventive care. However, pivotal limitations such as high test costs, limited insurance coverage, and the critical need for experienced genetic counselors challenge expansion. Additionally, ethical concerns regarding the implications of genetic testing pose significant hurdles. Nevertheless, the market holds promising opportunities, especially in emerging economies by expanding accessibility through cost-reduction strategies and mobile health technology integration. Strategic diversification into developing tests for detecting rare genetic conditions and enhancing privacy measures for sensitive genetic data can unlock further growth pathways. Collaborative efforts with policymakers to facilitate insurance coverage and subsidies can help overcome financial barriers. Meanwhile, continuous investment in R&D is crucial to address both technical accuracy and ethical considerations, bolstering the reliability and acceptance of NIPT. The market's dynamic nature indicates resilience and adaptability, yet underscores the necessity for companies to proactively innovate and align their offerings with evolving healthcare landscapes, societal ethics, and technological advancements to capture emerging opportunities and maintain competitive leadership.

Understanding Market Dynamics in the Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing incidence of chromosomal abnormalities with increasing maternal age
- Growing preference for non-invasive techniques over invasive methods
- Increased awareness among pregnant women about the benefits and availability of NIPT
Market Restraints
- Inadequate healthcare infrastructure and limited access to advanced medical technologies in rural or underdeveloped areas
Market Opportunities
- Providing comprehensive pre-test and post-test counseling services to enhance patient experience and uptake
- Development and approval of secure and reliable home-testing kits
Market Challenges
- Reliability of test results, especially in obese women

Exploring Porter’s Five Forces for the Non-invasive Prenatal Testing Market

Porter’s Five Forces framework further strengthens the insights of the Non-invasive Prenatal Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Non-invasive Prenatal Testing Market

External macro-environmental factors deeply influence the performance of the Non-invasive Prenatal Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-invasive Prenatal Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Berry Genomics Co. Ltd., BGI Group, BillionToOne, Inc., Biora Therapeutics, Inc., BioReference Laboratories, Inc., Centogene N.V., Eurofins LifeCodexx AG by Eurofins Scientific, F.Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., Igenomix, Illumina, Inc., Laboratory Corporation of America Holdings, Lilac Insights Pvt. Ltd., MedGenome Inc., Myriad Genetics, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., Sonic Healthcare Limited, Thermo Fisher Scientific Inc., and Yourgene Health by Novacyt UK Holdings Limited.

Market Segmentation & Coverage

This research report categorizes the Non-invasive Prenatal Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Assay Kits & Reagents
  - Disposables
- Instruments
  - Microarrays
  - Next-Generation Sequencing Systems
  - Polymerase Chain Reaction Instruments
  - Ultrasound Devices
Method
- Biochemical Screening Tests
- Cell-free DNA in Maternal Plasma Tests
- Fetal Cells in Maternal Blood Tests
- Ultrasound Detection
Test Type
- Harmony Test
- MaterniT21 Plus Test
- Panorama Test
- Verifi Test
Application
- Down Syndrome (Trisomy 21)
- Edwards Syndrome (Trisomy 18)
- Microdeletion Syndrome
- Patau Syndrome (Trisomy 13)
- Sex Chromosome Disorders
End User
- Diagnostic Laboratories
- Hospitals
- Research Institutes
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chromosomal abnormalities with increasing maternal age
5.1.1.2. Growing preference for non-invasive techniques over invasive methods
5.1.1.3. Increased awareness among pregnant women about the benefits and availability of NIPT
5.1.2. Restraints
5.1.2.1. Inadequate healthcare infrastructure and limited access to advanced medical technologies in rural or underdeveloped areas
5.1.3. Opportunities
5.1.3.1. Providing comprehensive pre-test and post-test counseling services to enhance patient experience and uptake
5.1.3.2. Development and approval of secure and reliable home-testing kits
5.1.4. Challenges
5.1.4.1. Reliability of test results, especially in obese women
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Non-invasive Prenatal Testing Market, by Product

6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits & Reagents
6.2.2. Disposables
6.3. Instruments
6.3.1. Microarrays
6.3.2. Next-Generation Sequencing Systems
6.3.3. Polymerase Chain Reaction Instruments
6.3.4. Ultrasound Devices

7. Non-invasive Prenatal Testing Market, by Method

7.1. Introduction
7.2. Biochemical Screening Tests
7.3. Cell-free DNA in Maternal Plasma Tests
7.4. Fetal Cells in Maternal Blood Tests
7.5. Ultrasound Detection

8. Non-invasive Prenatal Testing Market, by Test Type

8.1. Introduction
8.2. Harmony Test
8.3. MaterniT21 Plus Test
8.4. Panorama Test
8.5. Verifi Test

9. Non-invasive Prenatal Testing Market, by Application

9.1. Introduction
9.2. Down Syndrome (Trisomy 21)
9.3. Edwards Syndrome (Trisomy 18)
9.4. Microdeletion Syndrome
9.5. Patau Syndrome (Trisomy 13)
9.6. Sex Chromosome Disorders

10. Non-invasive Prenatal Testing Market, by End User

10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Research Institutes
10.5. Specialty Clinics

11. Americas Non-invasive Prenatal Testing Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Non-invasive Prenatal Testing Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Non-invasive Prenatal Testing Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Natera launches cfDNA-based fetal RhD test to combat RhIg shortage, ensuring 100% sensitivity, 99% specificity, and optimized patient care
14.3.2. BillionToOne launches BabyPeek, a non-invasive prenatal genetic test , expanding market reach and consumer choices while offering fun insights into unborn baby traits
14.3.3. Natera, Inc. acquires Invitae assets to enhance non-invasive prenatal testing offerings
14.4. Strategy Analysis & Recommendation
14.4.1. Natera, Inc.

List of Figures

FIGURE 1. NON-INVASIVE PRENATAL TESTING MARKET RESEARCH PROCESS
FIGURE 2. NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NON-INVASIVE PRENATAL TESTING MARKET DYNAMICS
TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HARMONY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MATERNIT21 PLUS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PANORAMA TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY VERIFI TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DOWN SYNDROME (TRISOMY 21), BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY EDWARDS SYNDROME (TRISOMY 18), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PATAU SYNDROME (TRISOMY 13), BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 63. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 64. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 65. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 72. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 100. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 101. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 102. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 107. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 109. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 121. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 122. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 123. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 163. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 164. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 165. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 187. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 188. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 192. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 194. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 199. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 201. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 202. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 206. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 208. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 209. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 213. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 215. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 216. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 227. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 228. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 229. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 230. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 248. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 250. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 255. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 257. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 262. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 263. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 264. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 291. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 292. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 293. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 311. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 313. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 314. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET S

Companies Mentioned

The leading players in the Non-invasive Prenatal Testing market, which are profiled in this report, include:

Agilent Technologies, Inc.
Berry Genomics Co. Ltd.
BGI Group
BillionToOne, Inc.
Biora Therapeutics, Inc.
BioReference Laboratories, Inc.
Centogene N.V.
Eurofins LifeCodexx AG by Eurofins Scientific
F.Hoffmann-La Roche Ltd.
GE HealthCare Technologies Inc.
Igenomix
Illumina, Inc.
Laboratory Corporation of America Holdings
Lilac Insights Pvt. Ltd.
MedGenome Inc.
Myriad Genetics, Inc.
Natera, Inc.
PerkinElmer Inc.
Quest Diagnostics Incorporated
Ravgen Inc.
Sonic Healthcare Limited
Thermo Fisher Scientific Inc.
Yourgene Health by Novacyt UK Holdings Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.75 Billion
Compound Annual Growth Rate	5.4%
Regions Covered	Global
No. of Companies Mentioned	23

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3397EUR$3,545USD£2,831GBP €3775EUR$3,939USD£3,145GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6011EUR$6,272USD£5,009GBP €6679EUR$6,969USD£5,565GBP

Understanding Market Dynamics in the Non-invasive Prenatal Testing Market

Exploring Porter’s Five Forces for the Non-invasive Prenatal Testing Market

Applying PESTLE Analysis to the Non-invasive Prenatal Testing Market

Analyzing Market Share in the Non-invasive Prenatal Testing Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Non-invasive Prenatal Testing Market

Strategic Recommendations for Success in the Non-invasive Prenatal Testing Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report by Gestation Period, Pregnancy Risk, Method, Technology, Product, Application, End-use, Region, and Segment Forecasts, 2024-2030

Non invasive Prenatal Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030

Non-Invasive Prenatal Testing Market Report by Product Type, Test Type, Technology, Method, Application, End-User, and Region 2024-2032

Non-invasive Prenatal Testing Global Market Report 2024

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report